Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9278733 | 0.97 | PPARG (0.95) | PPARGPPARA | |
| SCHEMBL9220837 | 0.92 | PPARG (0.86) | PPARGPPARA | |
| SCHEMBL2786495 | 0.92 | PPARG (0.84) | PPARGPPARA | |
| SCHEMBL9273453 | 0.91 | PPARG (0.83) | PPARGPPARA | |
| SCHEMBL6936735 | 0.90 | PPARG (0.82) | PPARGPPARA | |
| SCHEMBL9212839 | 0.90 | PPARG (0.81) | PPARGPPARA | |
| SCHEMBL6939250 | 0.89 | PPARG (0.81) | PPARGPPARA | |
| SCHEMBL9214334 | 0.89 | PPARG (0.80) | PPARGPPARA | |
| SCHEMBL9281649 | 0.88 | PPARG (0.79) | PPARGPPARA | |
| Trifluoroacetic Acid SCHEMBL7711576 | 0.88 | PPARG (0.78) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0916651-B1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | SANKYO CO (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-6103907-A | ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT | SANKYO COMPANY, LIMITED (JP) | 2000-08-15 | — | — | US | disclosed |
| CN-1219927-A | Phenylalkylcarboxylic acid derivatives | SANKYO CO (JP) | 1999-06-16 | — | — | CN | disclosed |
| EP-0916651-A1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 1999-05-19 | — | — | EP | disclosed |
| WO-1995003288-A1 | HETEROAROMATIC DERIVATIVES AND THEIR USE IN THERAPEUTICS | SMITHKLINE BEECHAM PLC (GB) | 1995-02-02 | — | — | WO | disclosed |